$66.95
-0.10[-0.15%]
At close: Apr 19
$66.95
0[0.00%]
After Hours: 4:00PM EDT
Axonics
(NASDAQ:AXNX)Axonics Stock (NASDAQ:AXNX), Analyst Ratings, Price Targets, Predictions
Axonics Inc has a consensus price target of $60.84, established from looking at the 61 latest analyst ratings. The last 3 analyst ratings were released from RBC Capital, Needham, and Truist Securities on February 29, 2024, January 17, 2024, and January 16, 2024. With an average price target of $47.33 between RBC Capital, Needham, and Truist Securities, there's an implied -29.30% downside for Axonics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Needham
Truist Securities
CL King
Piper Sandler
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Axonics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/29/2024 | AXNX | Buy Now | Axonics | $66.95 | 6.05% | RBC Capital | Shagun Singh | → $71 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 01/17/2024 | AXNX | Buy Now | Axonics | $66.95 | — | Needham | Mike Matson | — | Downgrade | Buy → Hold | Get Alert |
| 01/16/2024 | AXNX | Buy Now | Axonics | $66.95 | 6.05% | Truist Securities | David Rescott | $73 → $71 | Downgrade | Buy → Hold | Get Alert |
| 01/12/2024 | AXNX | Buy Now | Axonics | $66.95 | 6.05% | Truist Securities | David Rescott | $73 → $71 | Downgrade | Buy → Hold | Get Alert |
| 01/12/2024 | AXNX | Buy Now | Axonics | $66.95 | — | CL King | Kristen Stewart | — | Downgrade | Buy → Neutral | Get Alert |
| 01/12/2024 | AXNX | Buy Now | Axonics | $66.95 | 6.05% | Piper Sandler | Adam Maeder | $75 → $71 | Downgrade | Overweight → Neutral | Get Alert |
| 01/12/2024 | AXNX | Buy Now | Axonics | $66.95 | 6.05% | Leerink Partners | Mike Kratky | → $71 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/10/2024 | AXNX | Buy Now | Axonics | $66.95 | 6.05% | Wells Fargo | Larry Biegelsen | $68 → $71 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/09/2024 | AXNX | Buy Now | Axonics | $66.95 | — | Wolfe Research | Mike Polark | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 12/22/2023 | AXNX | Buy Now | Axonics | $66.95 | 9.04% | Truist Securities | David Rescott | $65 → $73 | Maintains | Buy | Get Alert |
| 10/31/2023 | AXNX | Buy Now | Axonics | $66.95 | 12.02% | Piper Sandler | Adam Maeder | $84 → $75 | Maintains | Overweight | Get Alert |
| 10/31/2023 | AXNX | Buy Now | Axonics | $66.95 | 3.06% | Morgan Stanley | Cecilia Furlong | $76 → $69 | Maintains | Overweight | Get Alert |
| 10/31/2023 | AXNX | Buy Now | Axonics | $66.95 | -5.9% | Needham | Mike Matson | $76 → $63 | Maintains | Buy | Get Alert |
| 10/16/2023 | AXNX | Buy Now | Axonics | $66.95 | 4.56% | Leerink Partners | Mike Kratky | → $70 | Initiates | → Outperform | Get Alert |
| 07/28/2023 | AXNX | Buy Now | Axonics | $66.95 | 4.56% | Baird | David Rescott | $69 → $70 | Maintains | Outperform | Get Alert |
| 07/28/2023 | AXNX | Buy Now | Axonics | $66.95 | 13.52% | Needham | Mike Matson | $73 → $76 | Maintains | Buy | Get Alert |
| 07/28/2023 | AXNX | Buy Now | Axonics | $66.95 | 6.05% | Keybanc | Matthew Mishan | $70 → $71 | Maintains | Overweight | Get Alert |
| 07/19/2023 | AXNX | Buy Now | Axonics | $66.95 | 3.06% | Baird | David Rescott | → $69 | Initiates | → Outperform | Get Alert |
| 07/14/2023 | AXNX | Buy Now | Axonics | $66.95 | 12.02% | Mizuho | Anthony Petrone | → $75 | Reiterates | Buy → Buy | Get Alert |
FAQ
What is the target price for Axonics (AXNX)?
The latest price target for Axonics (NASDAQ: AXNX) was reported by RBC Capital on February 29, 2024. The analyst firm set a price target for $71.00 expecting AXNX to rise to within 12 months (a possible 6.05% upside). 26 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Axonics (AXNX)?
The latest analyst rating for Axonics (NASDAQ: AXNX) was provided by RBC Capital, and Axonics reiterated their sector perform rating.
When was the last upgrade for Axonics (AXNX)?
The last upgrade for Axonics Inc happened on March 24, 2023 when Needham raised their price target to $71. Needham previously had a hold for Axonics Inc.
When was the last downgrade for Axonics (AXNX)?
The last downgrade for Axonics Inc happened on January 17, 2024 when Needham changed their price target from N/A to N/A for Axonics Inc.
When is the next analyst rating going to be posted or updated for Axonics (AXNX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axonics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axonics was filed on February 29, 2024 so you should expect the next rating to be made available sometime around February 28, 2025.
Is the Analyst Rating Axonics (AXNX) correct?
While ratings are subjective and will change, the latest Axonics (AXNX) rating was a reiterated with a price target of $0.00 to $71.00. The current price Axonics (AXNX) is trading at is $66.95, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.